Eptinezumab for early treatment of post-traumatic headaches
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if a medication called eptinezumab can help stop headaches that start after a head injury. If you have new headaches since your injury and they happen within the first 8 weeks, this study may offer early treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have headaches that started within 8 weeks after a head injury.
- You have migraine-like symptoms (like throbbing pain, nausea, or sensitivity to light/sound) at least once a week during screening.
- You are not taking certain migraine preventives like botulinum toxin or other CGRP drugs in the last 3 months.
- You have no other major health issues like uncontrolled depression, PTSD, or chronic pain disorders.
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares behavior therapy to education to help veterans with persistent headaches that started or got worse after a mild concussion. The goal is to find which approach better reduces headache-related disability.
This trial tests whether an IV dose of ketamine can reduce chronic daily headaches and is safe for people with this condition. It may help by lowering headache frequency and severity, but it also has several medicine and health-related safety checks.
This trial tests whether eptinezumab, a medication that reduces a brain chemical called CGRP (involved in migraines), can help reduce headaches in people with idiopathic intracranial hypertension (IIH)—a condition where pressure builds up around the brain. The study wants to see if this treatment safely reduces headache frequency and severity.
This trial tests if eptinezumab can stop a migraine attack that is already happening. It may help people who get migraines often and are already part of the TACHIS study.
This Phase 2 study tests a medication that blocks a pain signal (a CGRP receptor antibody) in people who recently had a mild traumatic brain injury (mTBI) and are also dealing with post-traumatic headache (PTH). The goal is to see if it can reduce symptoms and improve recovery after the injury.
This trial tests eptinezumab, a preventive medicine, to reduce headache frequency in teens with chronic migraine. It may help your teen if they have frequent migraine days despite usual care.
Hear when a new Post-Traumatic Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.